Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.
Researchers
-
Albert González Martin
Dermatologist
-
Anna Ravella Matthew
Dermatologist
PhD -
David Vidal Sarro
Dermatologist
PhD -
Gisela Hebe Petiti
Dermatologist
-
Joan Antoni Smandia Domínguez
Dermatologist
PhD -
Laura Peramiquel Fonollosa
Dermatologist
-
Loida Galvany Rosell
Dermatologist
-
Mª Rosa Olivella Garcés
Dermatologist
-
Maria López Nuñez
Dermatologist
-
Maria Villar Buil
Dermatologist
-
Nuria Lamas Domenech
Dermatologist
Contact the group
Form
Projects
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
OPTiMISE (Optimization of Maintenance Treatment with Secukinumab 300 mg) [Optimization of long-term maintenance treatment of white skin in patients with moderate to severe chronic plaque psoriasis: Randomized, multicenter, open-label study with blinded evaluation, comparative 52-week follow- up to evaluate the efficacy, safety and tolerability of secukinumab 300 mg sc
-
DISTRICT ATTORNEY:
Novartis
-
TYPE E:
RD2004
-
- Year 2015
- Comprehensive Care Center Dos de Maig Hospital
Analysis of gene expansion in lesional and non-lesional biopsy of a psoriatic patient in cultivation.
-
DISTRICT ATTORNEY:
Dr. Luis F. Santamaria
-
TYPE E:
PINE TREE
-
- Year 2015
- Comprehensive Care Center Dos de Maig Hospital
Study of inhibitors of the II-23/TH17 axis in cultures of Th17 lymphocytes in cultures of T lymphocytes and psoriatic epidemic cells in vitro.
-
DISTRICT ATTORNEY:
Dr. Luis F. Santamaria- UB
-
TYPE E:
PINE TREE
-
- Year 2015
- Sant Joan Despí Moisès Broggi Hospital
ECO-HS Study: Transversal and multicenter study to evaluate ultrasound as a characterization tool in the diagnosis of patients with hidradenitis suppurativa.
-
DISTRICT ATTORNEY:
Abbvie Spain, SLU
-
TYPE E:
PINE TREE
-
Dermatologist
Researcher
- Year 2014
- Comprehensive Care Center Dos de Maig Hospital
Study of inhibitors of the IL-23/Th17 axis in explants of psoriatic injured skin in vitro.
-
DISTRICT ATTORNEY:
Boch and Gimpera Foundation
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Observational study to evaluate relapses in patients with moderate-severe psoriasis treated with biological drugs according to clinical practice, in Spain. Estudio Bio PRESS.
-
DISTRICT ATTORNEY:
Novartis Farmaceútica, SA
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Retrospective study to evaluate the survival of metrotexano treatment in patients with psoriasis.
-
DISTRICT ATTORNEY:
Dr. David Vidal
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Usefulness of the PASE and EARP screening questionnaires for the diagnosis of enthesitis, synovitis and tenosynovitis in patients with psoriasis without a diagnosis of spondyloarthropathy.
-
DISTRICT ATTORNEY:
David Vidal
-
TYPE E:
PI
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Retrospective study to evaluate the survival of metrotexano treatment in patients with psoriasis.
-
DISTRICT ATTORNEY:
Dr. David Vidal
-
TYPE E:
EPA
-
- Year 2014
- Sant Joan Despí Moisès Broggi Hospital
Usefulness of the PASE and EARP screening questionnaires for the diagnosis of enthesitis, synovitis and tenosynovitis in patients with psoriasis without a diagnosis of spondyloarthropathy.
-
DISTRICT ATTORNEY:
David Vidal
-
TYPE E:
PINE TREE
Lines of action
- Immune mediated skin diseases
- Skin cancer
- neurofibromatosis
- Ultrasonography
